Primary Left Atrial Cardiopathy in Transthyretin Amyloidosis Cardiomyopathy by Multimodality Imaging: Implications for Thrombotic Events.
Benay Ozbay, Corey Rearick, Bharadwaj S Satyavolu...
https://pubmed.ncbi.nlm.nih.gov/40608042/Actively Recruiting
Led by University of Pittsburgh · Updated on 2026-01-07
900
Participants Needed
1
Research Sites
N/A
Total Duration
Cryptogenic stroke is a type of ischemic stroke where the cause of the blood clot is unknown, leaving many patients without a clear treatment plan and at high risk for another stroke. Researchers are investigating whether reduced function of the left atrium LA, the upper heart chamber that receives blood from the lungs, is associated with cryptogenic stroke and its recurrence, even when irregular heart rhythm atrial fibrillation, AF is not detected. This study aims to use a noninvasive ultrasound technique called strain imaging to measure LA function as a potential early biomarker for stroke risk. This multicenter observational study analyzes echocardiographic images from patients who had a stroke and underwent transthoracic echocardiography as part of their stroke evaluation. Participants include those with cryptogenic stroke and sinus rhythm, compared to those with non-cryptogenic strokes. The study evaluates LA strain, a sensitive measure of atrial function, using standardized software to assess its relationship to stroke occurrence and recurrence. Participants clinical and imaging data will be collected and analyzed centrally. Researchers will review follow-up information including stroke recurrence, development of atrial fibrillation, and mortality up to one year after the initial echocardiography. The primary outcome is the correlation between LA strain and cryptogenic stroke, with secondary outcomes assessing the prediction of recurrent stroke, cardiovascular death, and new AF detection. This study may help improve stroke prevention by identifying patients at risk earlier.
CONDITIONS
Left Atrial Strain and Cryptogenic Stroke
L
Leyla E Sade, MD
B
Benay Ozbay, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pittsburgh
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline
Participants undergo transthoracic echocardiography as part of stroke work up and have their echocardiographic images analyzed offline.
1 visit (in-person)
Duration - Up to 1 year from date of index transthoracic echocardiography.
Participants are monitored through clinical follow-up data collection for stroke recurrence, atrial fibrillation development, and mortality evaluation.
Follow-up visits as per routine clinical care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Benay Ozbay, Corey Rearick, Bharadwaj S Satyavolu...
https://pubmed.ncbi.nlm.nih.gov/40608042/Leyla Elif Sade, Suzan Keskin, Ufuk Can...
https://pubmed.ncbi.nlm.nih.gov/33206942/Dawn O Kleindorfer, Amytis Towfighi, Seemant Chaturvedi...
https://pubmed.ncbi.nlm.nih.gov/34024117/Amy Clark, Aaisha Ferkh, Jamie Vandenberg...
https://pubmed.ncbi.nlm.nih.gov/38308431/Leyla Elif Sade, Francesco Fluvio Faletra, Gianluca Pontone...
https://pubmed.ncbi.nlm.nih.gov/39812172/Gabriele Masini, Wendy Wang, Yuekai Ji...
https://pubmed.ncbi.nlm.nih.gov/40052267/Ankit Maheshwari, Faye L Norby, Riccardo M Inciardi...
https://pubmed.ncbi.nlm.nih.gov/36534978/Hooman Kamel, W T Longstreth, David L Tirschwell...
https://pubmed.ncbi.nlm.nih.gov/38324415/Mohammadali Habibi, Joao A C Lima, Irfan M Khurram...
https://pubmed.ncbi.nlm.nih.gov/25652181/Jeffrey J Goldberger, Rishi Arora, David Green...
https://pubmed.ncbi.nlm.nih.gov/26216085/University of Pittsburgh
Lead Sponsor